Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02414139
Title	Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (Geometry Mono-1)
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	lung non-small cell carcinoma
Therapies	Capmatinib
Age Groups:	adult \| senior
Covered Countries	USA \| SWE \| NOR \| NLD \| LBN \| ITA \| ISR \| GBR \| FRA \| ESP \| DEU \| BEL \| AUT \| ARG